Asset Details
Do you wish to reserve the book?
Effect of Praziquantel Treatment on the Nutritional Status of Children Infected with Schistosoma haematobium
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Effect of Praziquantel Treatment on the Nutritional Status of Children Infected with Schistosoma haematobium
Do you wish to request the book?
Effect of Praziquantel Treatment on the Nutritional Status of Children Infected with Schistosoma haematobium
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Effect of Praziquantel Treatment on the Nutritional Status of Children Infected with Schistosoma haematobium
2025
Overview
This quasi-experimental trial examined the relationship between Schistosoma haematobium infection and nutritional status, and the impact of single dose praziquantel (PZQ) therapy on undernutrition. A total of 353 children were examined, 112 of which were infected with S. haematobium and treated with PZQ. Children’s heights, weights, and mid-upper arm circumferences (MUAC) were measured at baseline and one month post-treatment. Infected children had significantly smaller mean BMI-for-age z-scores (BAZ) (−1.16 vs. 0.11, p < 0.01) and weight-for-age z-scores (WAZ) (−0.61 vs. −0.31, p = 0.03) than the uninfected ones at baseline. S. haematobium infection was associated with underweight (adjusted OR: 1.76, 95% CI: 1.63–1.90). One month after treatment, BAZ, WAZ, height for age z-scores (HAZ), and MUAC scores were comparable between treated and control children. However, there was a significant decrease in the prevalence of underweight among treated children, while no significant change was observed in the control group one month post-treatment. In conclusion, children infected with S. haematobium are likely to suffer from undernutrition; however, single dose PZQ therapy may not improve their nutritional status within one month of treatment. Future studies could have longer follow-up periods to better estimate the drug’s effect on nutrition.
Publisher
MDPI AG,MDPI
Subject
/ Anemia
/ Animals
/ Anthelmintics - administration & dosage
/ Anthelmintics - therapeutic use
/ Child
/ Children
/ Eggs
/ Female
/ Humans
/ Male
/ Nutritional Status - drug effects
/ Praziquantel - administration & dosage
/ Praziquantel - therapeutic use
/ Schistosoma haematobium - drug effects
/ Schistosomiasis haematobia - complications
/ Schistosomiasis haematobia - drug therapy
/ Thinness
/ Urine
